ALGEV Fundamental Analysis - GEVELOT SA

Fundamental Rating

Overall ALGEV gets a fundamental rating of 4 out of 10. We evaluated ALGEV against 103 industry peers in the Machinery industry. No worries on liquidiy or solvency for ALGEV as it has an excellent financial health rating, but there are worries on the profitability. ALGEV is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALGEV was profitable.

In the past year ALGEV had a positive cash flow from operations.

In the past 5 years ALGEV has always been profitable.

ALGEV had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of 1.21%, ALGEV is not doing good in the industry: 61.16% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of 1.52%, ALGEV is doing worse than 66.02% of the companies in the same industry.

With a Return On Invested Capital value of 0.76%, ALGEV is not doing good in the industry: 77.67% of the companies in the same industry are doing better.

Measured over the past 3 years, the Average Return On Invested Capital for ALGEV is significantly below the industry average of 8.77%.

		Industry Rank	Sector Rank
ROA	1.21%
ROE	1.52%
ROIC	0.76%

ROA(3y)2.68%

ROA(5y)2.17%

ROE(3y)3.82%

ROE(5y)3.1%

ROIC(3y)3.04%

ROIC(5y)2.57%

1.3 Margins

ALGEV has a Profit Margin (2.38%) which is comparable to the rest of the industry.

ALGEV's Profit Margin has declined in the last couple of years.

With a Operating Margin value of 1.68%, ALGEV is not doing good in the industry: 75.73% of the companies in the same industry are doing better.

In the last couple of years the Operating Margin of ALGEV has declined.

Looking at the Gross Margin, with a value of 63.62%, ALGEV belongs to the top of the industry, outperforming 88.35% of the companies in the same industry.

ALGEV's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	1.68%
PM (TTM)	2.38%
GM	63.62%

OM growth 3Y-37.75%

OM growth 5Y-26.99%

PM growth 3Y-30.66%

PM growth 5Y-22.17%

GM growth 3Y-1.14%

GM growth 5Y-0.99%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALGEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

ALGEV has less shares outstanding than it did 1 year ago.

ALGEV has less shares outstanding than it did 5 years ago.

The debt/assets ratio for ALGEV is higher compared to a year ago.

2.2 Solvency

ALGEV has an Altman-Z score of 3.66. This indicates that ALGEV is financially healthy and has little risk of bankruptcy at the moment.

With an excellent Altman-Z score value of 3.66, ALGEV belongs to the best of the industry, outperforming 80.58% of the companies in the same industry.

A Debt/Equity ratio of 0.03 indicates that ALGEV is not too dependend on debt financing.

With an excellent Debt to Equity ratio value of 0.03, ALGEV belongs to the best of the industry, outperforming 87.38% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	3.66

ROIC/WACC0.1

WACC7.66%

2.3 Liquidity

ALGEV has a Current Ratio of 5.18. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 5.18, ALGEV belongs to the best of the industry, outperforming 98.06% of the companies in the same industry.

ALGEV has a Quick Ratio of 3.79. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.

ALGEV has a better Quick ratio (3.79) than 98.06% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.18
Quick Ratio	3.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALGEV have decreased strongly by -75.10% in the last year.

ALGEV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.19% yearly.

ALGEV shows a decrease in Revenue. In the last year, the revenue decreased by -8.66%.

Measured over the past years, ALGEV shows a small growth in Revenue. The Revenue has been growing by 5.90% on average per year.

EPS 1Y (TTM)-75.1%

EPS 3Y-22.49%

EPS 5Y-17.19%

EPS Q2Q%-126.43%

Revenue 1Y (TTM)-8.66%

Revenue growth 3Y10.91%

Revenue growth 5Y5.9%

Sales Q2Q%-8.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y3.55%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year3.03%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 40.27, ALGEV can be considered very expensive at the moment.

Based on the Price/Earnings ratio, ALGEV is valued a bit more expensive than 61.16% of the companies in the same industry.

When comparing the Price/Earnings ratio of ALGEV to the average of the S&P500 Index (27.20), we can say ALGEV is valued slightly more expensively.

A Price/Forward Earnings ratio of 13.00 indicates a correct valuation of ALGEV.

ALGEV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALGEV is cheaper than 62.14% of the companies in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, ALGEV is valued a bit cheaper.

		Industry Rank	Sector Rank
PE	40.27
Fwd PE	13

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALGEV is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	13.05

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)11.35

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALGEV has a Yearly Dividend Yield of 2.84%. Purely for dividend investing, there may be better candidates out there.

Compared to an average industry Dividend Yield of 2.88, ALGEV pays a better dividend. On top of this ALGEV pays more dividend than 82.52% of the companies listed in the same industry.

ALGEV's Dividend Yield is comparable with the S&P500 average which is at 2.38.

		Industry Rank	Sector Rank
Dividend Yield	2.84%

5.2 History

On average, the dividend of ALGEV grows each year by 21.15%, which is quite nice.

Dividend Growth(5Y)21.15%

Div Incr Years4

Div Non Decr Years5

5.3 Sustainability

ALGEV pays out 117.62% of its income as dividend. This is not a sustainable payout ratio.

The dividend of ALGEV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP117.62%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

GEVELOT SA

EPA:ALGEV (9/15/2025, 7:00:00 PM)

176

0 (0%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)N/A N/A

Earnings (Next)10-30 2025-10-30

Inst Owners1.21%

Inst Owner ChangeN/A

Ins Owners7.72%

Ins Owner ChangeN/A

Market Cap132.00M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.84%

Yearly Dividend5.17

Dividend Growth(5Y)21.15%

DP117.62%

Div Incr Years4

Div Non Decr Years5

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	40.27
Fwd PE	13
P/S	0.96
P/FCF	N/A
P/OCF	30.56
P/B	0.61
P/tB	0.62
EV/EBITDA	13.05

EPS(TTM)4.37

EY2.48%

EPS(NY)13.53

Fwd EY7.69%

FCF(TTM)-3.7

FCFYN/A

OCF(TTM)5.76

OCFY3.27%

SpS184.19

BVpS288.75

TBVpS284.6

PEG (NY)11.35

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.21%
ROE	1.52%
ROCE	1%
ROIC	0.76%
ROICexc	0.85%
ROICexgc	0.87%
OM	1.68%
PM (TTM)	2.38%
GM	63.62%
FCFM	N/A

ROA(3y)2.68%

ROA(5y)2.17%

ROE(3y)3.82%

ROE(5y)3.1%

ROIC(3y)3.04%

ROIC(5y)2.57%

ROICexc(3y)3.55%

ROICexc(5y)3.63%

ROICexgc(3y)3.61%

ROICexgc(5y)3.72%

ROCE(3y)3.99%

ROCE(5y)3.37%

ROICexcg growth 3Y-45.56%

ROICexcg growth 5Y-35.96%

ROICexc growth 3Y-45.2%

ROICexc growth 5Y-34.4%

OM growth 3Y-37.75%

OM growth 5Y-26.99%

PM growth 3Y-30.66%

PM growth 5Y-22.17%

GM growth 3Y-1.14%

GM growth 5Y-0.99%

F-Score6

Asset Turnover0.51

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	0.85
Cap/Depr	107.05%
Cap/Sales	5.14%
Interest Coverage	250
Cash Conversion	48.26%
Profit Quality	N/A
Current Ratio	5.18
Quick Ratio	3.79
Altman-Z	3.66

F-Score6

WACC7.66%

ROIC/WACC0.1

Cap/Depr(3y)120.29%

Cap/Depr(5y)120.78%

Cap/Sales(3y)5.31%

Cap/Sales(5y)6.23%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-75.1%

EPS 3Y-22.49%

EPS 5Y-17.19%

EPS Q2Q%-126.43%

EPS Next Y3.55%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-8.66%

Revenue growth 3Y10.91%

Revenue growth 5Y5.9%

Sales Q2Q%-8.45%

Revenue Next Year3.03%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-81.83%

EBIT growth 3Y-30.96%

EBIT growth 5Y-22.68%

EBIT Next Year84.55%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-180.3%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-51.26%

OCF growth 3Y-10.1%

OCF growth 5Y-0.33%

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens